SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-011571
Filing Date
2024-04-10
Accepted
2024-04-10 07:46:20
Documents
14
Period of Report
2024-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240409_8k.htm   iXBRL 8-K 39459
  Complete submission text file 0001437749-24-011571.txt   178773

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240410.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240410_def.xml EX-101.DEF 11808
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240410_lab.xml EX-101.LAB 15859
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240410_pre.xml EX-101.PRE 12023
18 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240409_8k_htm.xml XML 2949
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 24834272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)